In Vitro Activation Following Ovarian Tissue Cryopreservation: A Case of Patient with POI

[1]  Shangwei Li,et al.  Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis , 2017, Scientific Reports.

[2]  Lauren M. Ataman,et al.  Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe , 2017, Journal of global oncology.

[3]  R. Cífková,et al.  ESHRE Guideline: management of women with premature ovarian insufficiency. , 2016, Human reproduction.

[4]  Y. Morimoto,et al.  Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. , 2015, Human reproduction.

[5]  W. Wallace,et al.  Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.

[6]  A. Carnero,et al.  The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models , 2014, Front. Oncol..

[7]  Y. Morimoto,et al.  Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment , 2013, Proceedings of the National Academy of Sciences.

[8]  Y. Morimoto,et al.  Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. , 2010, Reproductive biomedicine online.

[9]  C. Lambalk,et al.  A systematic review of tests predicting ovarian reserve and IVF outcome. , 2006, Human reproduction update.

[10]  Jared C. Robins,et al.  Embryo morphology score on day 3 is predictive of implantation and live birth rates , 2006, Journal of Assisted Reproduction and Genetics.